Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - COST OF REVENUE
Cost of Revenue KYMR - Kymera Therapeutics, Inc.
189 M
LAST VALUE
788.16%
2 YEAR CAGR
291.72%
5 YEAR CAGR
0.00%
10 YEAR CAGR